Robert A. Mendes

From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report

D. Berman, M. Budoff, L. Shaw, 2006 .

Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.

Robert A. Mendes, D. Dills, C. Zheng, 2015, Journal of managed care & specialty pharmacy.

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.

Yoram Rudy, Morteza Naghavi, John Rumberger, 2006, The American journal of cardiology.

Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice

Robert A. Mendes, D. Dills, N. Rashid, 2015, Journal of the American Heart Association.

Reimbursement Considerations In the Treatment of Hypercholesterolemia: Economics and Implications for Medical Groups

Robert A. Mendes, D. Hilleman, S. Crespin, 1999 .

The SHAPE Guideline: Why Primary Care Physicians Should Embrace It

Robert A. Mendes, 2011 .

Impact of High‐Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years

Robert A. Mendes, M. Koren, Theodore Feldman, 2009, Clinical cardiology.